332 related articles for article (PubMed ID: 26510913)
41. Silibinin induces apoptosis of HT29 colon carcinoma cells through early growth response-1 (EGR-1)-mediated non-steroidal anti-inflammatory drug-activated gene-1 (NAG-1) up-regulation.
Woo SM; Min KJ; Kim S; Park JW; Kim DE; Chun KS; Kim YH; Lee TJ; Kim SH; Choi YH; Chang JS; Kwon TK
Chem Biol Interact; 2014 Mar; 211():36-43. PubMed ID: 24440808
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of Eph receptor A4 by 2,5-dimethylpyrrolyl benzoic acid suppresses human pancreatic cancer growing orthotopically in nude mice.
Takano H; Nakamura T; Tsuchikawa T; Kushibiki T; Hontani K; Inoko K; Takahashi M; Sato S; Abe H; Takeuchi S; Sato N; Hiraoka K; Nishihara H; Shichinohe T; Hirano S
Oncotarget; 2015 Dec; 6(38):41063-76. PubMed ID: 26516928
[TBL] [Abstract][Full Text] [Related]
43. Silibinin inhibits endometrial carcinoma via blocking pathways of STAT3 activation and SREBP1-mediated lipid accumulation.
Shi Z; Zhou Q; Gao S; Li W; Li X; Liu Z; Jin P; Jiang J
Life Sci; 2019 Jan; 217():70-80. PubMed ID: 30452972
[TBL] [Abstract][Full Text] [Related]
44. Anti-tumor activities of luteolin and silibinin in glioblastoma cells: overexpression of miR-7-1-3p augmented luteolin and silibinin to inhibit autophagy and induce apoptosis in glioblastoma in vivo.
Chakrabarti M; Ray SK
Apoptosis; 2016 Mar; 21(3):312-28. PubMed ID: 26573275
[TBL] [Abstract][Full Text] [Related]
45. Mitochondrial p32 is upregulated in Myc expressing brain cancers and mediates glutamine addiction.
Fogal V; Babic I; Chao Y; Pastorino S; Mukthavaram R; Jiang P; Cho YJ; Pingle SC; Crawford JR; Piccioni DE; Kesari S
Oncotarget; 2015 Jan; 6(2):1157-70. PubMed ID: 25528767
[TBL] [Abstract][Full Text] [Related]
46. Silibinin induces cell death through reactive oxygen species-dependent downregulation of notch-1/ERK/Akt signaling in human breast cancer cells.
Kim TH; Woo JS; Kim YK; Kim KH
J Pharmacol Exp Ther; 2014 May; 349(2):268-78. PubMed ID: 24472723
[TBL] [Abstract][Full Text] [Related]
47. Silibinin suppresses in vivo growth of human prostate carcinoma PC-3 tumor xenograft.
Singh RP; Deep G; Blouin MJ; Pollak MN; Agarwal R
Carcinogenesis; 2007 Dec; 28(12):2567-74. PubMed ID: 17916909
[TBL] [Abstract][Full Text] [Related]
48. JNK signaling contributes to skeletal muscle wasting and protein turnover in pancreatic cancer cachexia.
Mulder SE; Dasgupta A; King RJ; Abrego J; Attri KS; Murthy D; Shukla SK; Singh PK
Cancer Lett; 2020 Oct; 491():70-77. PubMed ID: 32735910
[TBL] [Abstract][Full Text] [Related]
49. Combined treatment with silibinin and either sorafenib or gefitinib enhances their growth-inhibiting effects in hepatocellular carcinoma cells.
Gu HR; Park SC; Choi SJ; Lee JC; Kim YC; Han CJ; Kim J; Yang KY; Kim YJ; Noh GY; No SH; Jeong JH
Clin Mol Hepatol; 2015 Mar; 21(1):49-59. PubMed ID: 25834802
[TBL] [Abstract][Full Text] [Related]
50. Potent inhibitory effect of silibinin from milk thistle on skin inflammation stimuli by 12-O-tetradecanoylphorbol-13-acetate.
Liu W; Li Y; Zheng X; Zhang K; Du Z
Food Funct; 2015 Dec; 6(12):3712-9. PubMed ID: 26345246
[TBL] [Abstract][Full Text] [Related]
51. Detection of Pancreatic Cancer-Induced Cachexia Using a Fluorescent Myoblast Reporter System and Analysis of Metabolite Abundance.
Winnard PT; Bharti SK; Penet MF; Marik R; Mironchik Y; Wildes F; Maitra A; Bhujwalla ZM
Cancer Res; 2016 Mar; 76(6):1441-50. PubMed ID: 26719527
[TBL] [Abstract][Full Text] [Related]
52. Growth inhibition and regression of lung tumors by silibinin: modulation of angiogenesis by macrophage-associated cytokines and nuclear factor-kappaB and signal transducers and activators of transcription 3.
Tyagi A; Singh RP; Ramasamy K; Raina K; Redente EF; Dwyer-Nield LD; Radcliffe RA; Malkinson AM; Agarwal R
Cancer Prev Res (Phila); 2009 Jan; 2(1):74-83. PubMed ID: 19139021
[TBL] [Abstract][Full Text] [Related]
53. Pancreatic cancer induces muscle wasting by promoting the release of pancreatic adenocarcinoma upregulated factor.
Yoo W; Choi H; Son YH; Lee J; Jo S; Jung D; Kim YJ; Koh SS; Yang YR; Kwon ES; Lee KP; Noh KH; Kim KW; Ko Y; Jun E; Kim SC; Kim S
Exp Mol Med; 2021 Mar; 53(3):432-445. PubMed ID: 33731895
[TBL] [Abstract][Full Text] [Related]
54. Local and Systemic Cytokine Profiling for Pancreatic Ductal Adenocarcinoma to Study Cancer Cachexia in an Era of Precision Medicine.
Gerber MH; Underwood PW; Judge SM; Delitto D; Delitto AE; Nosacka RL; DiVita BB; Thomas RM; Permuth JB; Hughes SJ; Wallet SM; Judge AR; Trevino JG
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30513792
[TBL] [Abstract][Full Text] [Related]
55. Her4 promotes cancer metabolic reprogramming via the c-Myc-dependent signaling axis.
Han J; Zhang Y; Xu J; Zhang T; Wang H; Wang Z; Jiang Y; Zhou L; Yang M; Hua Y; Cai Z
Cancer Lett; 2021 Jan; 496():57-71. PubMed ID: 33038488
[TBL] [Abstract][Full Text] [Related]
56. Silibinin inhibits translation initiation: implications for anticancer therapy.
Lin CJ; Sukarieh R; Pelletier J
Mol Cancer Ther; 2009 Jun; 8(6):1606-12. PubMed ID: 19509268
[TBL] [Abstract][Full Text] [Related]
57. Beneficial effects of the naturally occurring flavonoid silibinin on the prostate cancer microenvironment: role of monocyte chemotactic protein-1 and immune cell recruitment.
Ting H; Deep G; Kumar S; Jain AK; Agarwal C; Agarwal R
Carcinogenesis; 2016 Jun; 37(6):589-599. PubMed ID: 27207648
[TBL] [Abstract][Full Text] [Related]
58. Therapeutic Targeting of the Warburg Effect in Pancreatic Cancer Relies on an Absence of p53 Function.
Rajeshkumar NV; Dutta P; Yabuuchi S; de Wilde RF; Martinez GV; Le A; Kamphorst JJ; Rabinowitz JD; Jain SK; Hidalgo M; Dang CV; Gillies RJ; Maitra A
Cancer Res; 2015 Aug; 75(16):3355-64. PubMed ID: 26113084
[TBL] [Abstract][Full Text] [Related]
59. Mas Receptor Activation Slows Tumor Growth and Attenuates Muscle Wasting in Cancer.
Murphy KT; Hossain MI; Swiderski K; Chee A; Naim T; Trieu J; Haynes V; Read SJ; Stapleton DI; Judge SM; Trevino JG; Judge AR; Lynch GS
Cancer Res; 2019 Feb; 79(4):706-719. PubMed ID: 30420474
[TBL] [Abstract][Full Text] [Related]
60. Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia.
Shukla SK; Gebregiworgis T; Purohit V; Chaika NV; Gunda V; Radhakrishnan P; Mehla K; Pipinos II; Powers R; Yu F; Singh PK
Cancer Metab; 2014; 2():18. PubMed ID: 25228990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
